SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-064452
Filing Date
2022-03-03
Accepted
2022-03-03 16:54:09
Documents
9
Period of Report
2022-03-03

Document Format Files

Seq Description Document Type Size
1 6-K d311056d6k.htm 6-K 21666
2 EX-4.1 d311056dex41.htm EX-4.1 702799
3 EX-4.3 d311056dex43.htm EX-4.3 167060
4 GRAPHIC g311056g0302235744321.jpg GRAPHIC 1795
5 GRAPHIC g311056g0302235744602.jpg GRAPHIC 2134
6 GRAPHIC g311056g0302235744930.jpg GRAPHIC 2016
7 GRAPHIC g311056g0302235745227.jpg GRAPHIC 2047
8 GRAPHIC g311056g0302235745555.jpg GRAPHIC 1798
9 GRAPHIC g311056g0302235745868.jpg GRAPHIC 2691
  Complete submission text file 0001193125-22-064452.txt   910672
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2AQ
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2AQ 011 44 1786 430411
LumiraDx Ltd (Filer) CIK: 0001685428 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40852 | Film No.: 22709908
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences